Previous studies have demonstrated that SOAT1 was involved in the formation of atherosclerotic plaques, and thus might be a promising target for atherosclerosis and hypercholesterolemia treatment [25,26]. This evidence concerns the gene SOAT1 and Hypercholesterolemia.